Sona Nanotech Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-08-17 Financing
Report of exempt distribution (45-106F1).pdf
Ownership 2026-08-14
2 insiders · +$90k net
Insider trading – 2026-08-14
2 insiders · +$90k net
Transactions 2026-08-10 Financing
Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds
News release - English.pdf
Transactions 2026-07-31 Financing
SONA NANOTECH TO ARRANGE PRIVATE PLACEMENT FINANCING
News release - English.pdf
Results 2026-06-29
Interim MD&A - English.pdf
Results 2026-06-29
Interim financial statements/report – English.pdf
News 2026-05-05
Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma
News release - English.pdf
Results 2026-04-27
Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences
News release - English.pdf
News 2026-04-13
Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies
News release - English.pdf
News 2026-04-07
Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination With Immunotherapy In Peer-reviewed Preclinical Study
News release - English.pdf
Results 2026-03-31
Interim MD&A - English.pdf
Results 2026-03-31
Interim financial statements/report – English.pdf
News 2026-03-24
Other.pdf
News 2026-03-24
Other.pdf
News 2026-03-17
Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study
News release - English.pdf
Results 2026-02-25 Financials
Annual MD&A - English.pdf
Results 2026-02-25 Financials
Audited annual financial statements – English.pdf
News 2025-10-20
News release - English.pdf
News 2025-10-17
News release - English.pdf
Results 2025-09-29 Financials
Interim MD&A - English.pdf
Results 2025-09-29 Financials
Interim financial statements/report – English.pdf